Exploring Patient and Physician Experiences of Medical Acupuncture
Public ClinicalTrials.gov record NCT02855593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The proposed qualitative inquiry seeks to understand medical acupuncture from both the physician and the patient perspective. Interviewees will be asked to describe their experiences from the point of diagnosis or training up until the present day to capture the nature of their experiences across the treatment trajectory. Sample size for the qualitative data collection will be based on saturation of themes (thematic findings, e.g., patient talk is limited by family knowledge or physician-patient communication is limited by time constraints in the clinical setting), meaning investigators will continue recruitment until they are no longer hearing new experiences from participants. Saturation will be kept separate by groups (i.e., saturation of themes must be met within the group of patients separately from providers). Investigators will conduct preliminary data analysis after each 10 interviews to determine when saturation is reached. Recruitment numbers here are anticipated maximum numbers needed to reach saturation. Investigators plan to recruit and sample provider and patient populations in the following way. Investigators will group physicians by the physician's training so that we are sensitive to the fact that helpful patient-physician interaction approaches may differ across the patient's lifespan or with patient or physician experience with acupuncture. Audio recordings from each interview will be professionally transcribed and analysis will be concurrent with data collection to ensure reliability and validity of findings. Investigators will review transcripts as data are collected to identify emergent themes and ensure thematic saturation.
Study identification
- NCT ID
- NCT02855593
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 65 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Jan 11, 2026
2016 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mike O'Callaghan Federal Medical Center | Nellis Air Force Base | Nevada | 89191 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02855593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02855593 live on ClinicalTrials.gov.